암 환자에서의 임상시험용 의약품 처방 오류 분석
Analysis of Prescribing Errors of Investigational Drugs in Oncology Clinical Trials
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective : Investigational drugs are often considered to be high-risk or hazardous medications. It is necessary to study medication errors in clinical trials. This study aimed at identifying the frequency and types of prescribing errors in oncology clinical trials. Methods : We retrospectively analyzed investigational drug orders and pharmacist intervention records from December 2015 to February 2017 in the National Cancer Center. Results : Among 12,387 investigational drug orders, 673 (5.43%) prescribing errors were detected by pharmacists. Regarding the route of administration, the prescription error rate related to IV medications was higher than that of oral medications (7.23% vs. 4.34%). The most common prescribing error in IV medications were wrong medication kit number (164 cases, 48.52 %) followed by incorrect diluent (75 cases, 22.19%), wrong dose (70 cases, 20.71%), and omission of information (20 cases, 5.92%). Meanwhile, the most common prescribing error in oral medications were wrong medication kit number (119 cases, 35.52 %) followed by incorrect quantity (67 cases, 20.0%), wrong dose (58 cases, 17.31%), and incorrect treatment duration (45 cases, 13.43%). Conclusions : This study provides the frequency and types of prescribing errors in oncology clinical trials. The pharmacist intervention may improve safety of investigational drug use.
Abstract
Objective : Investigational drugs are often considered to be high-risk or hazardous medications. It is necessary to study medication errors in clinical trials. This study aimed at identifying the frequency and types of prescribing errors in oncology clinical trials. Methods : We retrospectively analyzed investigational drug orders and pharmacist intervention records from December 2015 to February 2017 in the National Cancer Center. Results : Among 12,387 investigational drug orders, 673 (5.43%) prescribing errors were detected by pharmacists. Regarding the route of administration, the prescription error rate related to IV medications was higher than that of oral medications (7.23% vs. 4.34%). The most common prescribing error in IV medications were wrong medication kit number (164 cases, 48.52 %) followed by incorrect diluent (75 cases, 22.19%), wrong dose (70 cases, 20.71%), and omission of information (20 cases, 5.92%). Meanwhile, the most common prescribing error in oral medications were wrong medication kit number (119 cases, 35.52 %) followed by incorrect quantity (67 cases, 20.0%), wrong dose (58 cases, 17.31%), and incorrect treatment duration (45 cases, 13.43%). Conclusions : This study provides the frequency and types of prescribing errors in oncology clinical trials. The pharmacist intervention may improve safety of investigational drug use.
참고문헌 (14)
- Cohen M.R., "Medication Errors", pp.21~ (2007), American Pharmacists Association
- Franklin BD, "The incidence of prescribing errors in hospital inpatients : an overview of the research methods", Drug Safety, 28(10), pp.891~900 (2005)
- "HOPA investigational drug service best practice standards"[URL]
- Brown JN, "Medication safety in clinical trials : role of the pharmacist in optimizing practice, collaboration, and education to reduce errors", Yale J Biol Med, 90, pp.125~133 (2017)
- Kane MP, "Medication safety in cancer clinical trials: An analysis of medication error reports at a comprehensive cancer center", J Clin Oncol, 25(18_suppl), pp.6547~ (2007)
- "의약품 임상시험 관리기준(제30조제1항관련)", 국가법령정보센터[URL]
- "2018Current status on clinical trial approval in Korea" (2018)[URL]
- 남지나, "항암화학요법의 처방 검토 시 약사가 중재한 처방 오류 내용 분석", 병원약사회지, 25(2), pp.1~10 (2008), 한국병원약사회[DOI]
- 이현주, "약사에 의해 탐지된 항암제 처방오류 분석", 한국임상약학회지, 20(2), pp.120~127 (2010), 한국임상약학회
- 강민경, "약사의 항암제 처방감사를 통한 약물오류 예방", 병원약사회지, 28(3), pp.288~295 (2011), 한국병원약사회[DOI]
- 유소현, "약사에 의한 항암처방 중재 분석 및 처방 오류 개선 효과", 병원약사회지, 29(2), pp.131~138 (2012), 한국병원약사회[DOI]
- Han JM, "Clinical and economic impact of pharmacists’intervention in a large volume chemotherapy preparation unit", Int J Clin Pharm, 38(5), pp.1124~1132 (2016)
- Vantard N, "EPICC study : evaluation of pharmaceutical intervention in cancer care", J Clin Pharm Ther, 40, pp.196~203 (2015)
- Tamer H, "Using preprinted medication order forms to improve the safety of investigational drug use", Am J Health-Syst Pharm, 63(11), pp.1022~1028 (2006)